This Viewpoint questions recent US state regulations authorizing the use of cannabis as a substitute for opioids in treatment of opioid addiction and chronic pain, citing the absence of evidence of cannabis equivalency, the risks of marijuana use, and ample evidence supporting the use of methadone and buprenorphine for management of opioid use disorder (OID).
